|
|
|
Volumn , Issue 10, 2014, Pages 102-108
|
|
[Vasin new fluoroquinolones in treatment of patients with infectious lesions in diabetic foot syndrome]
a a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
MOXIFLOXACIN;
QUINOLONE DERIVATIVE;
CLASSIFICATION;
CLINICAL TRIAL;
DIABETIC FOOT;
DOSE RESPONSE;
DRUG COMBINATION;
DRUG EFFECTS;
DRUG MONITORING;
FEMALE;
HUMAN;
ISOLATION AND PURIFICATION;
MALE;
MICROBIOLOGY;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PATHOPHYSIOLOGY;
PROCEDURES;
SEVERITY OF ILLNESS INDEX;
STAPHYLOCOCCAL INFECTIONS;
STAPHYLOCOCCUS AUREUS;
TREATMENT OUTCOME;
ANTI-BACTERIAL AGENTS;
COMBINED MODALITY THERAPY;
DIABETIC FOOT;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG MONITORING;
DRUG THERAPY, COMBINATION;
FEMALE;
FLUOROQUINOLONES;
HUMANS;
MALE;
MIDDLE AGED;
SEVERITY OF ILLNESS INDEX;
STAPHYLOCOCCAL INFECTIONS;
STAPHYLOCOCCUS AUREUS;
SURGICAL PROCEDURES, OPERATIVE;
TREATMENT OUTCOME;
|
|
EID: 84925582313
PISSN: 00231207
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|